Arcadia Biosciences, Inc.
RKDANASDAQBasic Materials● Active
$0.92
$-0.15(-13.57%)
Market Cap$1430959
P/E Ratio—
52W High$6.71
52W Low$0.8
Arcadia Biosciences, Inc. (RKDA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RKDA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.86M | $5.04M | $4.45M | $7.42M | $6.78M |
| Cost of Revenue | $3.10M | $2.96M | $2.17M | $6.10M | $8.71M |
| Gross Profit | $1.76M | $2.08M | $2.28M | $1.32M | ($1.93M) |
| Gross Margin %(computed) | 36.23% | 41.27% | 51.19% | 17.75% | -28.44% |
| Operating Expenses | |||||
| R&D Expenses | $0.01M | $0.05M | $0.06M | $1.51M | $3.89M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $11.76M | $5.73M | $8.38M | $15.32M | $33.60M |
| Operating Income | ($9.99M) | ($3.65M) | ($6.10M) | ($14.01M) | ($35.53M) |
| Operating Margin %(computed) | -205.74% | -72.31% | -137.00% | -188.82% | -523.98% |
| Interest Income | $0.22M | $0.78M | $0.69M | $0.29M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.02M |
| Income Before Tax | ($2.33M) | ($4.31M) | ($5.32M) | ($10.81M) | ($16.13M) |
| Income Tax Expense | $0.01M | $0.01M | $0.01M | $0.01M | $0.00M |
| Net Income | ($2.34M) | ($7.04M) | ($13.98M) | ($15.38M) | ($14.66M) |
| Net Margin %(computed) | -48.15% | -139.50% | -313.90% | -207.28% | -216.22% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.71 | $-5.16 | $-11.30 | $-26.05 | $-30.33 |
| Wtd Avg Shares | 1.37M | 1.36M | 1.24M | 0.60M | 0.53M |
| EBITDA | ($9.96M) | ($7.50M) | ($5.73M) | ($14.75M) | ($27.71M) |
| EBITDA Margin %(computed) | -205.08% | -148.64% | -128.67% | -198.83% | -408.70% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Arcadia Biosciences, Inc. data
About Arcadia Biosciences, Inc. (RKDA) Income Statement
Arcadia Biosciences, Inc. (RKDA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RKDA reported revenue of $0.00B, gross profit of $0.00B (gross margin 36.23%), and net income of ($0.00B) — a net profit margin of -48.15%.
Frequently asked questions
RKDA · 4 questionsArcadia Biosciences, Inc. (RKDA) reported revenue of $0.00B for 2025, down 3.7% year-over-year.
RKDA revenueRKDA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08